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Background/Objective: Chronic renal failure can lead to nail disorders. The aim of this study was to
investigate nail disorders and laboratory data in patients on constant hemodialysis (HD) in a hospital in
Qazvin, Iran.
Methods: A case-controlled study was performed. End stage renal disease patients (n ¼ 149) undergoing
regular HD and 147 randomly selected individuals were examined for nail disorder. All participants were
examined by two trained students and a single dermatologist. Speciﬁc investigations such as nail biopsy,
potassium hydroxide mount, and fungal culture were done if necessary. Laboratory data were completed
for HD patients. Demographic characteristics, the causes of end stage renal disease, and laboratory data
were tested in a multivariate analysis.
Results: In this study, 62 HD patients had at least one nail disorder, with leukonychia being the most
common in both groups. Clinical onychomycosis, absent lunula and half and half nail were the other
common ﬁndings in HD patients. Positive mycological culture was noted in four HD patients and in none
of the control individuals. The mean duration of HD was a signiﬁcant predictor associated with the
positive clinical onychomycosis (p < 0.05). Although there was no signiﬁcant correlation between nail
disorders and hypertension or heart failure, multiple logistic regression analysis indicated that gender,
age  65 years, and diabetes mellitus (DM) were associated with nail disorder.
Conclusion: The prevalence of nail disorder in this study was correlated with age, DM, and gender. To
decrease the prevalence of nail disorder, attention to duration of HD, age, male sex, and DM is very
important.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Chronic renal failure (CRF) can lead to skin and nail disorders.
Changes in skin color, xerosis, pruritis, metastatic calcinosis,
bullous dermatosis, and perforating disorders have been seen in
patients with CRF.1 These abnormalities may develop before or
after initiation of hemodialysis (HD).2 Many of these uremic related
dermatologic abnormalities improve after kidney transplantation.1
The prevalence of nail disorders may be as high as 71.4 %. 3 Various
studies have reported skin and nail disorders in patients with
chronic renal disease undergoing dialysis; however, few of these
were controlled studies conducted to compare the prevalence of
these disorders in patients undergoing dialysis and in healthy
individuals in the general population.1,4e6 The nail disorders mostl Research Develop Unit, Boo
nces, Qazvin, Iran. Tel.: þ98
ivand).
iwanese Dermatological Associatiocommonly found in patients with CRF are: half and half nails
(HHN),1,5,7 absent lunula (AL),1,5 and splinter hemorrhages.1,5,8 In
HHN, the proximal half is white, while the distal portion is red to
brown.9 AL is a condition characterized by absence of the visible
portion of the nail matrix, while splinter hemorrhages appear as
dark red, ﬁliform, longitudinal lines in the distal region of the nail
plate and may also be associated with antiphospholipid antibody
syndrome, bacterial endocarditis, trichinosis, onychomatricoma,
and external trauma.9 The pathogenesis of nail involvement in
patients with renal failure is poorly deﬁned.4 The aim of our study
was to investigate nail disorders and laboratory data in patients on
constant HD in hemodialysis centers of a hospital in Qazvin, Iran
and compare them with a paired sample of individuals selected at
random from the general population.
Methods
A case-controlled study was performed. There were 149 end-stage
renal disease (ESRD) patients undergoing chronic HD for at leastn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 The causes of ESRD in the patients of the present study. ATN ¼ acute tubular
necrosis; DM ¼ diabetes mellitus; GN ¼ glomerulonephritis; HTN ¼ hypertension;
UTI ¼ urinary tract infections.
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the friends and relatives accompanying patients at the hospital
who were examined for nail disorders in Boo-Ali-Sina Hospital in
Qazvin. Exclusion criteria included: history of renal transplant,
active malignancy, collagen vascular diseases, active infection,
cirrhosis, immunosuppressive medication, human immune deﬁ-
ciency virus infection, and alcohol abuse. A questionnaire that
included age, sex, underlying cause of ESRD, coexistence diseases,
duration of HD, medication, dialysis quality (Kt/V), and laboratory
data, including hemoglobin, leukocyte count, calcium, phospho-
rous, albumin, creatinine, blood urea nitrogen (BUN), alkaline
phosphatase (ALP), alanine aminotransferase, aspartate amino-
transfrase, iron, ferritin, total iron binding capacity, and parathyroid
hormone (PTH), was completed for each HD patient. Blood samples
were drawn from the patients and controls under fasting condi-
tions and immediately before the dialysis session in patients. All
patients and the control group were examined by two trained
students and a single meticulous dermatologist. Speciﬁc investi-
gations such as nail biopsy, culture and sensitivity for potassium
hydroxide (KOH) mount, and fungal culture were done if necessary.
After a thorough examination of the ﬁngers and toenails, nail
scrapings were obtained from 38 HD patients and 11 control indi-
viduals who expressed suspicious nail changes. If onychomycosis
(OM) was suspected, microscopic examination of the nail scrapings
was performed with the use of 20% KOH solution. (The KOH test
was performed on all 38 HD patients and 11 controls.) Samples
were cultured on Sabouraud dextrose agar (Sigma Chemical Co., St
Louis, MO, USA). Cultures were incubated at 26C and examined
twice aweek for a total duration of 4 weeks. If a mouldwas isolated,
it was regarded as pathogenic when directmicroscope examination
was positive and culture, repeated three times at 7 day intervals,
led to isolation of a pure culture of the mould positive in a number
of inoculations. The criteria for the diagnosis of OM were the same
as all moulds isolated in the study period. Dermatophytes and
moulds were identiﬁed on the basis of macro- and microscopic
characters of colonies according to the criteria of Rebell and Taplin
for dermatophytes and De Hoog et al for moulds.10 Phosphorus,
creatinine, and BUN were determined with a standard auto-
analyzer. Ionized calcium was determined using a calcium-speciﬁc
electrode. Total ALP was determined using a commercial enzyme
linked immunoassay kit (ELISA; normal range 40e190 IU/L). PTH
was determined using an immunoﬂuorimetric assay that detects
the intact PTH molecule (normal range 10e70 pg/mL).11 A colori-
metric method was used to determine serum albumin. The quality
of HD was assessed during the study period by calculating Kt/V
using the Daugirdas formula, as described in the Dialysis Outcomes
Quality Initiative guidelines.12
The collected data were analyzed using SPSS software (version
11.0; SPSS Inc, Chicago, IL, USA). The Fisher’s exact Chi-square test and
theStudent t testwereused toassess statistical relationshipsbetween
variables. Demographic characteristics, medical data, and laboratory
test data were subjected to a multivariate analysis. Continuous data
are presented as mean  standard deviation. A p-value <0.05 was
considered signiﬁcant.
The study was approved by the ethics committee of the
university before its initiation, and the protocols used conformed to
the ethical guidelines of the 1975 Helsinki Declaration. All patients
were informed about the study protocol and the written consent
was obtained from all participants.
Results
Of 149 HD patients, 96 (64.4%) weremale. Mean agewas 55.9 16.1
years (range 13e91 years) and the mean dialysis duration was
40.85  42.64 months (range 3e228 months). In the control group,88 (59.8%) weremale andmean agewas 55.7 17.9 years (range 8e
75 years). The causes of ESRD in the patient cohort are shown in
Figure 1.
Overall, 62 HD patients and 36 control individuals had at least
one nail disorder. There were 96 nail lesions identiﬁed in HD
patients and 38 in the control group, as some of the patients had
more than one nail disorder. The prevalence rates of the different
types of nail disorders are shown in (Table 1).
Of the 62 HD patients (all HD cases had nail disorders), 47 were
male, 24 were age 65 years, 31 were positive for diabetes mellitus
(DM), 28 were positive for hypertension, and 11 were positive for
heart failure. The presence of nail disorders in HD patients was
shown to be statistically related to sex, DM, and age (Table 2).
Leukonychia was the most common nail change in both patients
and controls. Other common ﬁndings in HD patients were clinical
OM, AL, and HHN followed by splinter hemorrhage, onycholysis,
pitting, culture positive OM, thin nail, undiagnosable lesion, sub-
ungual hyperkeratosis, koilonychia, cyanosis, pincer nail, melano-
nychia, and clubbing. In the control group, after leukonychia, AL and
onycolysis were the most common nail disorders. Furthermore, the
prevalence of clinical diagnosis of OM was established in 11 HD
patients and two controls according to the presence of both positive
clinical signs (such as discoloration of nails, changes in nail thick-
ness) and positive KOH test. Positive mycological culture was noted
in four HD patients in case group and in none of patients in control
group (Table 3). None of the patients had a positive familial history
or history of nail trauma, tight and high heeled or traumatic shoes,
and excessive sweating of foot during activity. The clinical and
biochemical characteristics of the HD patients are shown in Table 4.
The results of our study showed that the mean duration of HD in
patients with positive clinical OM was more than that in those
without (p < 0.05). Apart from serum ALP, alanine aminotrans-
ferase, aspartate aminotransfrase, and total iron binding capacity
(p < 0.05), the other clinical and biochemical parameters had no
statistically signiﬁcant differences in either group.
Discussion
CRF is a known cause for several nail pathologies. Nail abnormali-
ties have been reported in 60% to 76% of patients undergoing HD.4,6
In a case-control study, Saray et al reported at least one type of
nail pathology in 69.8% of HD patients and 39.2% of a control group.
Table 3 The frequency of isolated fungi toenail scraping cultures in case group.
Isolated fungus n (%) of culture(þ)
Trichophyton rubrum D 2 (1.4%)
Trichophyton mentagrophytes D 1 (0.7%)
Epidermophyton D 1 (0.7%)
D ¼ dermatophyte.
Table 4 The frequency of isolated fungi toenail scraping cultures in case group.
Parameters Positive clinical
onycomycosis
(n ¼ 11)
Negative clinical
onycomycosis
(n ¼ 138)
p
Age (y) 59.7  16.6 (29e81) 55.6  16.1 (13e91) 0.446
Sex Male ¼ 81.8% Male ¼ 63% _
Duration (mo) 69.5  40 (8e120) 38.6  42.2 (3e228) 0.032*
Weekly Kt/V 2.5  0.96 (1.2e4.2) 2.5  0.91 (1.2e7.02) 1.000
Hb (g/dL) 10  1.5 (7.6e12) 10.7  1.8 (6.3e16) 0.168
AST (IU) 13  4 (10e23) 19  13 (8e86) 0.001*
ALT (IU) 14  5 (10e26) 18  12 (5e99) 0.040*
TIBC (mg/dL) 243  30 (200e300) 289  135 (122e1120) 0.003*
Fe (mg/dL) 127  223 (30e800) 114  158 (20e829) 0.853
Table 1 The prevalence rates of nail lesions in hemodialysis and control.
Nail disorder Control (n ¼ 147) Case (n ¼ 149) p
Leukonychia 10 (6.8%) 23 (15.4%) 0.017*
Absent lunula 6 (4%) 11 (7.3%) 0.220
Clinical onycomycosis 2 (1.3%) 11 (7.3%) 0.020*
Half and half 2 (1.3%) 10 (6.7%) 0.035*
Splinter hemorrhage 3 (2%) 8 (5.3%) 0.218
Onycholysis 5 (3.4%) 7 (4.7%) 0.571
Pitting 3 (2%) 5 (3.3%) 0.723
Culture (þ) onycomycosis 0 4 (2.7%) 0.122
Thin nail 3 (2%) 3 (2%) 1.000
Undiagnosable lesion 2 (1.3%) 3 (2%) 1.000
Subungual hyperkeratosis 1 (0.6%) 3 (2%) 0.622
Koilonychia 0 2 (1.3%) 0.498
Cyanosis 1 (0.6%) 2 (1.3%) 1.000
Pincer nail 0 2 (1.3%) 0.498
Melanonychia 0 1 (0.7%) 1.000
Clubbing 0 1 (0.7%) 1.000
Total 38 (25.8%) 96 (64.4%) 0.000*
Clinical onycomycosis: if there was the presence of both positive clinical signs (such
as discoloration of nails, changes in nail thickness) and positive KOH test. Negative
clinical onycomycosis: if either positive clinical signs (such as discoloration of nails,
changes in nail thickness) or positive KOH test were not present.
*A p-value <0.05 was considered signiﬁcant.
M. Charkhchian et al. / Dermatologica Sinica 31 (2013) 7e10 9In this study AL, OM, and splinter hemorrhage were the most
common disorders. The overall prevalence of nail pathology in this
study was not correlated with age, sex, and HD duration, although
they showed a possible relationship between HD duration and OM
(p ¼ 0.05).1
In another study Dyachenko et al reported nail disorder in 11.6%
of controls, 60.3% of CRF and 62.3% of HD patients. The most
common disorders in controls, in CRF patients, and in patients on
HD were: OM; AL, OM, and HHN; and HHN, AL, and OM, respec-
tively. Male gender, age above 65 years, DM, hypertension, heart
failure, and PTH above 220 mEq/mL were the most important risk
factors in this study but duration of HD was not important.4
Salam et al reported at least one nail disorder in 76% of HD
patients and 30% of controls. In this study HHN was the most
common ﬁnding followed by AL, onycholysis, brittle nail, beau’s
nail, clubbing, longitudinal ridging, OM, and other disorders. They
did not ﬁnd signiﬁcant correlation between nail pathology and
duration of HD.6
In the study by Maha et al on 100 patients undergoing regular
HD, koilonychia, HHN, and splinter hemorrhages were the three
common diseases13 (Table 5 summarizes the results of our study
and the other studies).
We found 62 HD patients (41.6%) and 36 controls (24.5%) with
nail disorders. Leukonychia (15.4%), AL (7.3%), clinical OM (7.3%),
HHN (6.7%), splinter hemorrhage (5.3%) and onycholysis (4.7%)
were the most common ﬁndings in HD patients, while leukonychia
(6.8%) and AL (4%) were the most common in the control group.
Although there was no signiﬁcant correlation between nail
disorders and hypertension [odds ratio (OR) ¼ 1.735, 95% conﬁ-
dence interval (CI) 0.886e3.400] and heart failure (OR ¼ 1.125, 95%
CI 0.473e2.676), multiple logistic regression analysis indicated that
male sex (OR ¼ 2.430, 95% CI 1.184e4.988), DM (OR ¼ 3.143, 95% CI
1.562e6.324) and age  65 years (OR ¼ 1.331, 95% CI 0.674e2.629)Table 2 Multivariate logistic regression analysis for overall nail disorders.
Factors OR (95% CI) p
Male 2.430 (1.184-4.988) 0.010
DM 3.143 (1.562-6.324) 0.001
HTN 1.735 (0.886-3.400) 0.108
Age  65 y 1.331 (0.674-2.692) 0.041
HF 1.125 (0.473-2.676) 0.792
DM ¼ diabetes mellitusis; HF ¼ heart failure; HTN ¼ hypertension.were associated with nail disorders. These results clearly indicate
a relationship between nail disorders and DM and gender in HD
patients.
Leukonychia or white nail is the most common form of color
change, where the nail appears opaque and white, probably owing
to the diffraction of light in the abnormal keratotic cells; with
polarized light, the nail structure appears disrupted owing to
disorganization of the keratin ﬁbrils.14 This condition may be
present under clinical circumstances such as renal failure, pneu-
monia or heart disease or induced by the use of cytotoxic drugs or
poisoning with arsenic. Some considerations to keep in mind
regarding leukonychia are that its presence is not a sign of a lack of
vitamin or calcium in the diet, it is harmless and may be caused
simply from a minor injury that occurs when the nail is growing,
and that it is much more common on ﬁngernails than toenails. This
disorder was found to have high prevalence in our study both in
patients and controls, although the difference in prevalence
between the two groups was not signiﬁcant (p ¼ 0.446).
Clinical OM was the second most common disorder in HD
patients in our study. The prevalence of OM in general population is
about 2% to 11%15e18 and in HD patients it rises to 6.2% to 52%.5,8
This higher frequency of OM may stem from impaired cellular
immunity in these patients.19
The risk factors that have been associatedwith OM are older age,
swimming, tinea pedis, psoriasis, DM, immunodeﬁciency, and
living with family members who have OM.15,20,21 OM is an infection
of the nail apparatus with fungi including dermatophytes, non-
dermatophyte moulds, and yeasts (mainly Candida spp.). The
toenails are affected in 80% of all cases with OM; dermatophyte
infection, mostly due to Trichophyton rubrum, is the cause in over
90% of cases.10 OM may eventually progress to total nail dystrophy
in which the nail plate is almost completely destroyed. Treatment
should not be instituted on clinical grounds alone. Although 50% of
all cases of nail dystrophy are fungal in origin it is not always
possible to identify such cases accurately.22Ca (mg/dL) 8.5  1.1 (7e10.4) 8.5  0.7 (6e10) 1.000
P (mg/dL) 6.6  1.8 (4.4e10) 6.9  2 (2e13) 0.608
Ferritin (mg/L) 438  420 (117e1600) 293  267 (17e2000) 0.286
ALP (IU/L) 663  385 (208e1300) 398  268 (56e2000) 0.049*
PTH (pg/mL) 761  998 (24e2900) 458  516 (26e3100) 0.343
Albumin (g/dL) 4.1  0.3 (3.6e4.6) 4.2  0.6 (2e6) 0.349
ALP ¼ alkaline phosphatase; ALT ¼ alanine aminotransferase; AST ¼ aspartate
aminotransferase; Duration ¼ duration of hemodialysis; Hb ¼ hemoglobin; Kt/
V ¼ quality of dialysis; PTH ¼ parathyroid hormone; TIBC ¼ total iron binding
capacity.
*A p-value <0.05 was considered signiﬁcant.
Table 5 Comparison of common nail disorders in our study and other studies.
Disorders Our study Saray et al1 Dyachenko et al4 Maha et al13 Salem et al6
Iran Turkey Israel Egypt Egypt
Leukonychia 15.4% 10.4% 7.8% unknown 2%
Absent lunula 7.3% 31.9% 13% unknown 17%
Culture (þ) onycomycosis 2.7% 19.2% 10.4% unknown 4%
Half and half 6.7% 7.7% 16.9% 28% 20%
Splinter hemorrhage 5.3% 13.7% 3.9% 16% 2%
Onycholysis 4.7% 1.1% 7.8% 3% 7%
Koilonychia 3.3% 2.7% unknown 39% 3%
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diabetic and 57.7% of non-diabetic HD patients had dystrophic nail
changes; 26.6% of all patients showed OM according to both posi-
tive clinical sign and positive KOH test; toenail scraping cultures
were positive in 19.7% of patients with dystrophic nail changes; and
DM and duration of HD increased the prevalence of OM (OR 4.0232
and 1.2499).
In our study, clinical OMwas diagnosed in 11 HD patients (7.3%).
Although only four of them had a positive culture, Trichophyton
rubrum was the most frequently isolated organism from the
cultures, followed by Trichophyton mentagrophytes and Epi-
dermophyton. In concordance with previous studies we found that
three culture positive patients were diabetic24,25; however, the
prevalence of culture positive OM in our study was low in
comparison with other published studies.4,23 Mean duration of HD
in patients with positive clinical OM was higher than the same
mean in negative clinical OM (p < 0.05). This result is in agreement
with the Kuvandik et al study.23
HHNwas the fourthmost commondisorder inHDpatients in our
study. This disorder, ﬁrst reported by Bean in 1963,26 is the white
appearance of proximal half of the nail, due to nail bed edema
associatedwith dilated capillaries despite the fact that the other half
of the nail bed appears normal.27 The etiology of this disorder
remains unknown.7,28 In somepublications, HHNhad been reported
as representing the most common nail disorder in CRF patients on
HD.7,29 This disorder were the fourth common disorder in HD
patients in the present study (6.7%), with a signiﬁcant difference in
prevalence compared with the control group (p ¼ 0.035).
In our study, AL was the second most common ﬁnding in both
case and control groups. This result can be explained by the varied
etiology of this disorder such as anemia or malnutrition.
Our study suggests that nail disorders weremost common in HD
patients. Numerous factors inﬂuence the prevalence rate of these
conditions and their diagnosis. The difference between our ﬁndings
and the other similar studies on some speciﬁc nail manifestations
in patients on HD may be due to education, genetics, occupation,
and chance, in association with different physical and chemical
agents in the studied population.
In conclusion the prevalence of nail disorders is increased
among HD patients. In our study male sex, age  65 years, and DM
were important risk factors for nail disorders, and dialysis duration
and presence of DM were risk factors for OM. Leukonychia, OM, AL,
and HHN were the most common lesions. Periodic dermatologic
examination of nail in patients with ESRD is necessary. In addition,
to decrease the prevalence of OM and other nail disorders attention
to duration of HD, male sex, age  65 years, and DM is very
important.
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